Form EFFECT BRAINSTORM CELL THERAPEU
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 2, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Latitude Food Allergy Care Opens San Diego Clinic, Bringing Physician-led Treatment and Appointments Without the Wait
- Peregrine Technologies Raises $250 Million Series D at $6.8 Billion Valuation
- Magnit Global™ Launches Magnit Pulse™, Bringing Contingent Workforce Management into Workplace Communication Platforms
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
